Stock listing
Celon Pharma Sa
Selected listing: A2DJW6 · LS · EUR · DE
Celon Pharma Sa (Lang & Schwarz: A2DJW6), Health Technology. Latest release Oct 8, 2025: FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial.
- Ticker
- Lang & Schwarz: A2DJW6
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Celon Pharma Sa
FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial
October 8, 2025
Celon Pharma S A : Doubled export sales, continuation of the strategy of investing in research and development
September 29, 2021
Celon Pharma S A : Announces Successful Completion of Phase 1A Trial of CPL’116, JAK-ROCK Inhibitor.
February 10, 2021
Research Celon Pharma Sa
Alternate listings
CLN:GPW
PL · PLN
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
0RKX:LSE
GB · PLN
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
A2DJW6:LSX
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
8RP:GETTEX
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
8RP:DUS
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
8RP:FWB
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
8RP:MUN
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.
8RP:SWB
DE · EUR
Alternate listing for Celon Pharma Sa; the primary context on this page is A2DJW6:LS.